Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2001;38:309-316

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jin, X.-H.
Right arrow Articles by Carey, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jin, X.-H.
Right arrow Articles by Carey, R. M.
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Hypertension - basic studies

(Hypertension. 2001;38:309.)
© 2001 American Heart Association, Inc.


Scientific Contributions

Renal Interstitial cGMP Mediates Natriuresis by Direct Tubule Mechanism

Xiao-Hong Jin; Helmy M. Siragy; Robert M. Carey

Department of Medicine, University of Virginia, School of Medicine, Charlottesville.

Reprint requests to Dr Robert M. Carey, Box 800793, University of Virginia Health System, Charlottesville, VA 22908. E-mail RMC4c{at}virginia.edu

Abstract— The objective of this study was to test the hypothesis that renal interstitial (RI) cGMP is natriuretic in vivo. In conscious rats (n=8), urinary sodium excretion (UNaV) was significantly greater on days 3 and 4 of RI infusion of cGMP (1.17±0.14 and 1.61±0.11 mmol/24 h, respectively) than during vehicle infusion (0.56±0.15 and 0.70±0.17 mmol/24 h, respectively) (P<0.01). Similarly, UNaV was greater on days 3 and 4 of RI infusion of 8-bromo-cGMP (2.15±0.42 and 2.16±0.1 mmol/24 h, respectively). Protein kinase G inhibitor Rp-8-pCPT-cGMPS reduced cGMP-induced and 8-bromo-cGMP-induced UNaV to control levels. Acute RI infusion of L-arginine (L-Arg, 40 mg · kg-1 · min-1), but not D-arginine, caused an increase in UNaV from 1.65±0.11 to 4.07±0.1 µmol/30 min (P<0.01). This increase was blocked by RI infusion of NG-nitro-L-arginine methyl ester (100 ng · kg-1 · min-1) by the phosphodiesterase (PDE II) activator 5,6DMcBIMP (0.01 µmol/µL), by PDE II (0.03 U · kg-1 · min-1) itself, or by the soluble guanylyl cyclase inhibitor 1-H-[1,2,4]oxadiazolo-[4,2-{alpha}]quinoxalin-1-one (ODQ, 0.12 mg · kg-1 · min-1). The PDE II activator also blocked L-Arg-stimulated cGMP levels. The NO donor S-nitroso-N-acetylpenicillamine (SNAP, 0.12 µmol · L-1 · kg-1 · min-1) increased UNaV from 1.65±0.11 to 2.93±0.08 µmol/30 min (P<0.01), and this response was blocked completely by ODQ. Renal arterial but not RI administration of the heat-stable enterotoxin of Escherichia coli induced natriuresis. RA infusion of cGMP (3 µg/min) increased UNaV, renal blood flow (RBF), and glomerular filtration rate (GFR). Renal cortical interstitial cGMP infusion increased UNaV with no effect on total RBF, renal cortical blood flow, or GFR. Similarly, the natriuretic actions of renal interstitial L-Arg or SNAP were not accompanied by any change in RBF or GFR. Medullary cGMP infusion had no effect on UNaV, total RBF, or medullary blood flow. Texas red-labeled cGMP infused via the RI space was distributed exclusively to cortical renal tubular cells. The results demonstrate that RI cGMP inhibits renal tubular sodium absorption via protein kinase G independently of hemodynamic changes. These observations indicate that the cortical interstitial compartment provides a potentially important domain for cell-to-cell signaling within the kidney.


Key Words: cyclic GMP • kidney • natriuresis • sodium • protein kinases




This article has been cited by other articles:


Home page
HypertensionHome page
D. C. Lieb, B. A. Kemp, N. L. Howell, J. J. Gildea, and R. M. Carey
Reinforcing Feedback Loop of Renal Cyclic Guanosine 3' 5' -Monophosphate and Interstitial Hydrostatic Pressure in Pressure-Natriuresis
Hypertension, December 1, 2009; 54(6): 1278 - 1283.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Vera, S. Kelsen, and D. E. Stec
Response to Use of Protoporphyrins to Evaluate Heme Oxygenase Problematical
Hypertension, February 1, 2009; 53(2): e16 - e16.
[Full Text] [PDF]


Home page
HypertensionHome page
J. Park, B. A. Kemp, N. L. Howell, J. J. Gildea, S. R. Keller, and R. M. Carey
Intact Microtubules Are Required for Natriuretic Responses to Nitric Oxide and Increased Renal Perfusion Pressure
Hypertension, February 1, 2008; 51(2): 494 - 499.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. Ahmed, B. A. Kemp, N. L. Howell, H. M. Siragy, and R. M. Carey
Extracellular Renal Guanosine Cyclic 3'5'-Monophosphate Modulates Nitric Oxide and Pressure-Induced Natriuresis
Hypertension, November 1, 2007; 50(5): 958 - 963.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. M. Siragy, T. Inagami, and R. M. Carey
NO and cGMP mediate angiotensin AT2 receptor-induced renal renin inhibition in young rats
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1461 - R1467.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
H. Kobori, M. Nangaku, L. G. Navar, and A. Nishiyama
The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease
Pharmacol. Rev., September 1, 2007; 59(3): 251 - 287.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. C. Hakam, A. H. Siddiqui, and T. Hussain
Renal angiotensin II AT2 receptors promote natriuresis in streptozotocin-induced diabetic rats
Am J Physiol Renal Physiol, February 1, 2006; 290(2): F503 - F508.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. Bouley, N. Pastor-Soler, O. Cohen, M. McLaughlin, S. Breton, and D. Brown
Stimulation of AQP2 membrane insertion in renal epithelial cells in vitro and in vivo by the cGMP phosphodiesterase inhibitor sildenafil citrate (Viagra)
Am J Physiol Renal Physiol, June 1, 2005; 288(6): F1103 - F1112.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
X.-H. Jin, H. E. McGrath, J. J. Gildea, H. M. Siragy, R. A. Felder, and R. M. Carey
Renal Interstitial Guanosine Cyclic 3', 5'-Monophosphate Mediates Pressure-Natriuresis Via Protein Kinase G
Hypertension, May 1, 2004; 43(5): 1133 - 1139.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Sasaki, H. M. Siragy, J. J. Gildea, R. A. Felder, and R. M. Carey
Production and Role of Extracellular Guanosine Cyclic 3', 5' Monophosphate in Sodium Uptake in Human Proximal Tubule Cells
Hypertension, February 1, 2004; 43(2): 286 - 291.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. M. Carey and H. M. Siragy
Newly Recognized Components of the Renin-Angiotensin System: Potential Roles in Cardiovascular and Renal Regulation
Endocr. Rev., June 1, 2003; 24(3): 261 - 271.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. He, T. Podymow, J. Zimpelmann, and K. D. Burns
NO inhibits Na+-K+-2Cl- cotransport via a cytochrome P-450-dependent pathway in renal epithelial cells (MMDD1)
Am J Physiol Renal Physiol, June 1, 2003; 284(6): F1235 - F1244.
[Abstract] [Full Text] [PDF]